Mayumbine exhibits potential in pharmacological research due to its observed bioactive properties. It has been studied for its antimalarial activity, showing effectiveness against Plasmodium falciparum in vitro. Additionally, mayumbine demonstrates anti-inflammatory and analgesic effects, suggesting possible use in developing treatments for pain and inflammatory conditions. Its structural profile also supports investigation as a central nervous system modulator, with preliminary studies indicating mild sedative and anxiolytic-like effects in animal models. These properties make mayumbine a candidate for further exploration in drug development, particularly in tropical medicine and neuropharmacology.